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Introduction
Neuropathological damage induced by prions within the CNS is a characteristic hallmark of prion diseases. Along with prion deposition and neuronal
loss, striking changes in glial activation occur. Studying these changes within scrapie-infected mouse models reveals a tractable model to
investigate the mechanisms of neurodegeneration. Recently there have been numerous reports that gut microbiota influence neurodegeneration via
modulation of the CNS microglial population. Indeed studies in naive mice have suggested that lack of gut microbiota results in a reduction of
microglial activation state and subsequent severity of CNS innate immune responses when subjected to stimulation by lipopolysaccharide (LPS). We
therefore determined whether the host commensal microbiota may influence CNS prion disease pathogenesis and susceptibility.
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Methods
Germ-free mice were used to investigate the influence of the host
microbiota on CNS prion disease pathogenesis and susceptibility.
Germ-free mice and conventional mice (control) were injected with
22C mouse-passaged scrapie strains by the intracerebral or
intraperitoneal routes. Following exposure, survival times were
recorded and brains collected at the terminal stage of disease for
histopathology, image and morphometric analysis techniques.
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Results
Our data show that the host commensal microbiota did not influence
prion disease duration or susceptibility, as survival times, disease
incidences and neuropathological changes were identical in germ-
free and conventional mice when infected with the same strain of
prion disease agent via the same route.
Conclusions
Germ-free mice have been shown to have altered
microglial morphology in the naïve state when compared to
those from conventional mice. However, our data show that
at the terminal stage of prion disease, the neuropathological
changes and microglial morphology were indistinguishable
in brains from germ-free and conventional mice. Our data
show that the presence or absence of the host commensal
microbiota does not significantly influence the development
of disease-associated PrP deposition, prion-induced
vacuolation microglial activation and astrocyte activation,
affecting neither targeting nor intensity of each
neuropathological hallmark within the CNS during prion
disease.
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Figure 2. The commensal gut
microbiota does not influence the
magnitude or distribution of the
prion-induced vacuolation within the
brain at the terminal stage of prion
disease.
A) H&E stained brain sections used for
vacuolation scoring, each brain was
scored on a scale of 1–5 in nine grey
matter areas: G1, dorsal medulla; G2,
cerebellar cortex; G3, superior
colliculus; G4, hypothalamus; G5,
thalamus; G6, hippocampus; G7,
septum; G8, retrosplenial and adjacent
motor cortex; G9, cingulate and adjacent
motor cortex from mice were infected
with prions by the IC (B) or IP (C)
routes.
Figure 1. Absence of the
commensal gut microbiota in
germfree mice did not influence
the distribution of disease-
specific PrP within the brain.
Sections were immunostained to
detect PrP (brown) and
counterstained with haematoxylin
(blue), scale bar, 100 µm
Figure 3. Absence of the commensal gut microbiota in germfree
mice did not influence the distribution of microglia within the
brain.
A) Sections were immunostained to detect Iba1+ cells (brown) and
counterstained with haematoxylin (blue) in the brains of clinically-
affected conventionally-housed and germfree mice infected with prions
by the IC (B) or IP (C) routes. n = 6 mice/group, scale bar, 100 µm.
Figure 4. No significant differences between groups were observed in the
number of microglia within regions, or in the length of dendrites, number of
segments, branching points or terminal points on individual microglia.
A) Imaris-based reconstructions of Iba1+ microglia in the hippocampus region. B)
Imaris-based quantitative cell morphometry of Iba1+ microglia in the dorsal medulla
(left-hand panels) and hippocampus (right-hand panels) regions. From each group,
six individual mice were sampled, and data were collected from at least 25 individual
Iba1+ microglia within each brain region. Solid bars, conventionally-housed mice;
open bars, germfree mice.
Figure 5. Absence of the commensal gut microbiota in germfree
mice did not influence the distribution of microglia within the
brain.
A) Sections were immunostained to detect astrocytes (GFAP+ cells,
brown) and counterstained with haematoxylin (blue), scale bar, 100
µm. Analysed as above (Figure 3).
